Storys aus Bologna

Selecta Group

3

Selecta | Results Q3 in 2023

Menarini Silicon Biosystems

Menarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting

Bologna, Italy and Huntingdon Valley, Pa. (ots/PRNewswire) - Menarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH® CMMC assay, a Non-Invasive Liquid Biopsy for the Quantification and Molecular Characterization of Circulating ...

HARMONY Alliance

New HARMONY Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia (CLL) Research Results from HARMONY to facilitate tailored treatment choices in subtypes of blood cancer

The Hague, The Netherlands (ots/PRNewswire) - - Big Data analyses have produced novel insights that may improve the prognostication of patients with AML and CLL - These results may be used to identify high-risk patients and to make better-informed treatment choices in the future - The new data is presented at the ...

Netafim Ltd.

Netafim to Launch New Sustainability-Enhancing Innovations at International EIMA Exhibition

Bologna, Italy and Tel Aviv, Israel (ots/PRNewswire) - - AgTech leader to also share details of planned activity following acquisition of Dutch greenhouse provider Gakon in joint presentation Netafim, the global leader of sustainable precision irrigation solutions and agricultural projects, announced today it will ...

Alfa Wassermann/Norgine

XIFAXAN® 550mg (rifaximin-?) Registered for Reduction of Recurrence of Episodes of Overt Hepatic Encephalopathy in the EU*

Bologna, Italy And Amsterdam (ots/PRNewswire) - Alfa Wassermann and Norgine are pleased to announce that they have received European Marketing Authorisation for XIFAXAN(R) 550mg (rifaximin-alpha) / REFERO(R) / TARGAXAN(R) / TIXTELLER(R) in the reduction of recurrence of episodes of overt hepatic encephalopathy (HE) ...